3.8. UV-induced Effects

Regulatory requirements: According to the current Notes for Guidance of the Scientific Committee on Cosmetic Products and Non-Food Products (SCCNFP), cosmetic ingredients and mixtures of ingredients absorbing UV light (in particular UV filter chemicals used, for example, to ensure the light stability of cosmetics or used in sun protection products) should be tested for acute phototoxic and photogenotoxic potential. Testing for photosensitisation (immunological photoallergy) potential is not specifically required, but it is nevertheless often performed. Acute phototoxicity: Due to a thorough multi-stage and multi-centre validation trial (1992-1998) the In Vitro 3T3 Neutral Red Uptake Phototoxicity Test (3T3-NRU-PT) had already gained acceptance by the SCCNFP in 1998, and it is recommended by the EMEA/CPMP as a basic preclinical test for acute phototoxicity. It was accepted as Method No. 41 in Annex V to Directive 67/548/EEC in the year 2000, and was accepted as the new Test Guideline 432 by the OECD in 2002. The 3T3-NRU-PT is regarded as a basic screen for identifying acute phototoxic potential. Two additional in vitro tests, formally evaluated in controlled blind trials, the RBC Phototoxicity Test (RBC-PT) and the Human 3-D Skin Model Phototoxicity Test (H3D-PT), are regarded as useful and important adjunct tests to overcome some limitations of the 3T3-NRU-PT, namely the fairly low UVB tolerance of the 3T3 fibroblasts and the inability to model the bioavailability of test materials topically applied to the skin. In addition, the RBC-PT permits an evaluation of the phototoxic mechanisms involved. In conclusion, the identification of acute phototoxic hazards is now regarded as being sufficiently covered by in vitro tests, so that animal testing for that endpoint can now be 100% replaced. Photogenotoxicity: In the area of photogenotoxicity, almost the whole battery of in vitro genetic toxicity tests have been (or are currently being) converted into test protocols of photogenotoxicity tests. Tests exclusively predictive for gene mutation, for example, the Photo-Ames (P-Ames) Test and the Photo-Thymidine Kinase Test (P-TKT), have become less important than tests for clastogenic effects (for example, the Photo-Chromosome Aberration Test [P-CAT] and the Photo-Micronucleus Test [P-MNT]). In addition, a number of promising indicator tests, such as the Photo-Comet Assay (P-Comet) have been developed. Although routinely used, to date none of the new photogenotoxicity tests have been formally validated. Therefore, the P-MNT and the P-Comet are currently being evaluated in a formal interlaboratory validation study. It is expected that these in vitro photogenotoxicity test methods may become available as validated and accepted methods within the next five years. Photoallergy (Photosensitisation): In the area of photoallergy (photosensitisation), as development of predictive in vitro tests for delayed contact sensitisation (allergenicity) potential without the involvement of light, due to a lack of ability to model the complex mechanisms underlying allergy, no promising in vitro methods to predict photo-sensitisation potential are currently in sight (see the section on skin sensitisation). One in vitro screening method, which models the covalent binding of a light activated chemical to human serum albumin, may become relevant. However, while the binding of an excited chemical to proteins is a prerequisite for photoallergy, this is not a sufficient predictor on its own. The only promising alternatives currently under development are in vivo refinements, like the Photo Local Lymph Node Assay (PLLNA). Once a reliable and predictive in vitro test battery and strategy for the assessment of "dark" sensitisation potential have been developed and accepted, their adaptation into similar photosensitisation testing will become possible.

[1]  R. Tice,et al.  A simple technique for quantitation of low levels of DNA damage in individual cells. , 1988, Experimental cell research.

[2]  N. Tanaka,et al.  The photogenotoxicity of titanium dioxide particles. , 1997, Mutation research.

[3]  Horst Spielmann,et al.  In Vitro Phototoxicity Testing , 1994 .

[4]  R. Dunmore,et al.  Development of assays for the detection of photomutagenicity of chemicals during exposure to UV light. II. Results of testing three sunscreen ingredients. , 1992, Mutagenesis.

[5]  G. Kahn,et al.  Red blood cell hemolysis by photosensitizing compounds. , 1971, The Journal of investigative dermatology.

[6]  C. Winterbourn Free-radical production and oxidative reactions of hemoglobin. , 1985, Environmental health perspectives.

[7]  Michael Balls,et al.  A Study on UV Filter Chemicals from Annex VII of European Union Directive 76/768/EEC, in the In Vitro 3T3 NRU Phototoxicity Test , 1998, Alternatives to laboratory animals : ATLA.

[8]  M Liebsch,et al.  The International EU/COLIPA In Vitro Phototoxicity Validation Study: Results of Phase II (Blind Trial). Part 1: The 3T3 NRU Phototoxicity Test. , 1998, Toxicology in vitro : an international journal published in association with BIBRA.

[9]  C. Bourner,et al.  Photomutagenicity assays in bacteria: factors affecting assay design and assessment of photomutagenic potential of para-aminobenzoic acid. , 1994, Mutagenesis.

[10]  P. Kasper,et al.  The application of the micronucleus test in Chinese hamster V79 cells to detect drug-induced photogenotoxicity. , 1999, Mutation research.

[11]  R. Snyder,et al.  Photogenotoxicity of Fluoroquinolones in Chinese Hamster V79 Cells: Dependency on Active Topoisomerase II , 1999, Photochemistry and photobiology.

[12]  B. Homey,et al.  An intra-laboratory validation of the Integrated Model for the Differentiation of Skin Reactions (IMDS): discrimination between (photo)allergic and (photo)irritant skin reactions in mice , 2000, Archives of Toxicology.

[13]  Lutz Müller,et al.  Photochemical genotoxicity: principles and test methods. Report of a GUM task force. , 2004, Mutation research.

[14]  F. A. de la Iglesia,et al.  In vitro photogenotoxic activity of clinafloxacin: a paradigm predicting photocarcinogenicity. , 1999, Toxicology and applied pharmacology.

[15]  A. Ryu,et al.  In Vitro Alternatives and Phototoxicity Testing. I. Evaluation of In Vitro Phototoxicity Assays , 1999, Alternatives to laboratory animals : ATLA.

[16]  L. Marrot,et al.  Fluoroquinolones as chemical tools to define a strategy for photogenotoxicity in vitro assessment. , 2001, Toxicology in vitro : an international journal published in association with BIBRA.

[17]  L K Earl,et al.  An assessment of the phototoxic hazard of a personal product ingredient using in vitro assays. , 2003, Toxicology in vitro : an international journal published in association with BIBRA.

[18]  A. M. Api,et al.  In vitro assessment of phototoxicity , 1997 .

[19]  Robert Combes,et al.  The Use of Human Keratinocytes in the EU/COLIPA International In Vitro Phototoxicity Test Validation Study and the ECVAM/COLIPA Study on UV Filter Chemicals , 1999, Alternatives to laboratory animals : ATLA.

[20]  H. Schuppe,et al.  An integrated model for the differentiation of chemical-induced allergic and irritant skin reactions. , 1998, Toxicology and applied pharmacology.

[21]  S. McKiernan,et al.  In vitro micronucleus assay with Chinese hamster V79 cells - results of a collaborative study with in situ exposure to 26 chemical substances. , 2000, Mutation research.

[22]  N. Loprieno In vitro assay systems for testing photomutagenic chemicals. , 1991, Mutagenesis.

[23]  Hermann-Georg Holzhütter,et al.  In Vitro Phototoxicity Testing: Development and Validation of a New Concentration Response Analysis Software and Biostatistical Analyses Related to the Use of Various Prediction Models , 2002, Alternatives to laboratory animals : ATLA.

[24]  M. Hayashi,et al.  Further evaluation of an in vivo micronucleus test on rat and mouse skin: results with five skin carcinogens. , 2002, Mutation research.

[25]  P. Convert,et al.  A NEW METHOD FOR THE ASSESSMENT OF PHOTOTOXIC AND PHOTOALLERGIC POTENTIALS BY TOPICAL APPLICATIONS IN THE ALBINO GUINEA PIG , 1985 .

[26]  P. Kasper,et al.  The Relevance of Photomutagenicity Testing as a Predictor of Photocarcinogenicity , 1998 .

[27]  N. Gibson,et al.  Differential cytotoxicity and DNA-damaging effects produced in human cells of the Mer+ and Mer- phenotypes by a series of 1-aryl-3-alkyltriazenes. , 1986, Cancer research.

[28]  D. Averbeck,et al.  The Second ECVAM Workshop on Phototoxicity Testing , 2000, Alternatives to laboratory animals : ATLA.

[29]  W. Lovell A scheme for in vitro screening of substances for photoallergenic potential. , 1993, Toxicology in vitro : an international journal published in association with BIBRA.

[30]  O. Damour,et al.  Use of dermal equivalent and skin equivalent models for identifying phototoxic compounds in vitro , 1997, Photodermatology, photoimmunology & photomedicine.

[31]  N. Traynor,et al.  Photohaemolysis assay for drug phototoxicity complicated by 'bleaching' of released haemoglobin. , 1996, Toxicology in Vitro.

[32]  J. Prins Directive 2003/98/EC of the European Parliament and of the Council , 2006 .

[33]  J. Jose Photomutagenesis by chlorinated phenothiazine tranquilizers. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[34]  N. Traynor,et al.  Photogenotoxicity of Skin Phototumorigenic Fluoroquinolone Antibiotics Detected Using the Comet Assay , 1997, Photochemistry and photobiology.

[35]  M. Aardema,et al.  Photoclastogenicity—an improved protocol, its validation, and investigation of the photogenotoxicity of DMBA , 2002, Environmental and molecular mutagenesis.

[36]  M Balls Statement on the scientific validity of the 3T3 NRU PT test (an in vitro test for phototoxic potential) , 1998 .

[37]  W. von der Hude,et al.  Chemically induced micronucleus formation in V79 cells--comparison of three different test approaches. , 1999, Mutation research.

[38]  S Albertini,et al.  The photomutagenicity of fluoroquinolones in tests for gene mutation, chromosomal aberration, gene conversion and DNA breakage (Comet assay). , 1996, Mutagenesis.

[39]  P. Kasper,et al.  Use of the photo-micronucleus assay in Chinese hamster V79 cells to study photochemical genotoxicity. , 2002, Mutation research.

[40]  C. Rudd,et al.  Recommended protocols based on a survey of current practice in genotoxicity testing laboratories: II. Mutation in Chinese hamster ovary, V79 Chinese hamster lung and L5178Y mouse lymphoma cells. , 1991, Mutation research.

[41]  R. Snyder,et al.  Considerations on photochemical genotoxicity: Report of the International Workshop on Genotoxicity Test Procedures Working Group , 2000, Environmental and molecular mutagenesis.

[42]  M Liebsch,et al.  EEC/COLIPA project on in vitro phototoxicity testing: First results obtained with a Balb/c 3T3 cell phototoxicity assay. , 1994, Toxicology in vitro : an international journal published in association with BIBRA.

[43]  U. Pfannenbecker,et al.  Combined in vitro assay for photohaemolysis and haemoglobin oxidation as part of a phototoxicity test system assessed with various phototoxic substances. , 1994, Toxicology in vitro : an international journal published in association with BIBRA.

[44]  M. Hayashi,et al.  Study of a rat skin in vivo micronucleus test: data generated by mitomycin C and methyl methanesulfonate. , 1999, Mutation research.

[45]  S Albertini,et al.  Photomutagenesis test development: I. 8-Methoxypsoralen, chlorpromazine and sunscreen compounds in bacterial and yeast assays. , 1993, Mutation research.

[46]  R. Dunmore,et al.  Development of assays for the detection of photomutagenicity of chemicals during exposure to UV light--I. Assay development. , 1991, Mutagenesis.

[47]  U. Pfannenbecker,et al.  The Red Blood Cell Phototoxicity Test (Photohaemolysis and Haemoglobin Oxidation): EU/COLIPA Validation Programme on Phototoxicity (Phase II) , 2001, Alternatives to laboratory animals : ATLA.

[48]  M Liebsch,et al.  application of the human dermal model skin(2) ZK 1350 to phototoxicity and skin corrosivity testing. , 1995, Toxicology in vitro : an international journal published in association with BIBRA.

[49]  K J Johanson,et al.  Microelectrophoretic study of radiation-induced DNA damages in individual mammalian cells. , 1984, Biochemical and biophysical research communications.

[50]  M Liebsch,et al.  Quantitative in vitro assessment of phototoxicity using a human skin model, Skin2. , 1994, Photodermatology, photoimmunology & photomedicine.

[51]  Hermann-Georg Holzhütter,et al.  A General Measure of In Vitro Phototoxicity Derived from Pairs of Dose-Response Curves and its Use for Predicting the In Vivo Phototoxicity of Chemicals , 1997 .

[52]  K. Maier,et al.  Development of an in vitro test system with human skin cells for evaluation of phototoxicity. , 1991, Toxicology in vitro : an international journal published in association with BIBRA.

[53]  E. Walker,et al.  In Vitro Models for Cutaneous Phototoxicity , 1986 .

[54]  E Borenfreund,et al.  Toxicity determined in vitro by morphological alterations and neutral red absorption. , 1985, Toxicology letters.

[55]  H. Spielmann,et al.  [Development of a new in vitro test for dermal phototoxicity using a model of reconstituted human epidermis] , 1997, ALTEX.

[56]  B. Homey,et al.  A modified murine local lymph node assay for the differentiation of contact photoallergy from phototoxicity by analysis of cytokine expression in skin-draining lymph node cells. , 1998, Toxicology.

[57]  H. Spielmann Acute phototoxicity tesing , 2001 .

[58]  K. Furuhama,et al.  In vivo photochemical micronucleus induction due to certain quinolone antimicrobial agents in the skin of hairless mice. , 2002, Mutation research.

[59]  M D Barratt,et al.  Photochemical binding of photoallergens to human serum albumin: a simple in vitro method for screening potential photoallergens. , 1985, Toxicology letters.

[60]  H. Wulf,et al.  Phototoxicity to diuretics and antidiabetics in the cultured keratinocyte cell line HaCaT: evaluation by clonogenic assay and single cell gel electrophoresis Comet assay) , 2002, Photodermatology, photoimmunology & photomedicine.